Schedule 13G ownership disclosure
BARINTHUS BIOTHERAPEUTICS PL
American Depositary Shares, each representing one ordinary share · CUSIP: 91864C107
Event date: 2024-12-31
- Filing-level shares
- 3,384,513.00
- Percent of class
- 8.4%
- Frank W. Cawood
Shares: 3,384,513.00 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-000226
- Form type
- SCHEDULE 13G/A
- Filer
- Barinthus Biotherapeutics plc.
- CIK
- CIK 1828185
- Filed
- Feb 11, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership